8-K - Kura Oncology, Inc. | StockGist

Current Report Details

Event Type

Charter Amendment

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On January 28, 2026, the board of directors (the “Board”) of Kura Oncology, Inc. (the

Charter Amendment

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Amended and Restated Bylaws of Kura Oncology, Inc. 104 Cover Page Interactive D

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1